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Abstract
Background: Cassia angustifolia Vahl. (commonly known as senna makkai or cassia senna), native to Saudi Arabia,
Egypt, Yemen and also extensively cultivated in Pakistan, is a medicinal herb used traditionally to cure number of
diseases like liver diseases, constipation, typhoid, cholera etc. This study was conducted to evaluate the in-vitro
antimicrobial, antioxidant and anticancer assays and phytochemical constituents of aqueous and organic extracts of
C. angustifolia leaves.
Methods: The antimicrobial activities of C. angustifolia aqueous and organic (methanol, ethanol, acetone, ethyl
acetate) extracts were investigated by the disk diffusion method. These extracts were further evaluated for
antioxidant potential by the DPPH radical scavenging assay. Anticancer activities of the extracts were determined
by the MTT colorimetric assay. The total phenolic and flavonoid contents of C. angustifolia extracts were evaluated
by the Folin-Ciocalteu method and aluminum chloride colorimetric assay, respectively. The structures of the
bioactive compounds were elucidated by NMR and ESI-MS spectrometry.
Results: Bioactivity-guided screening of C. angustifolia extracts, led to the isolation and identification of three
flavonoids quercimeritrin (1), scutellarein (2), and rutin (3) reported for the first time from this plant, showed
significant anticancer activity against MCF-7 (IC50, 4.0 μg/μL), HeLa (IC50, 5.45 μg/μL), Hep2 (IC50, 7.28 μg/μL) and low
cytotoxicity against HCEC (IC50, 21.09 μg/μL). Significant antioxidant activity was observed with IC50 2.41 μg/mL
against DPPH radical. Moreover, C. angustifolia extracts have the potential to inhibit microbial growth of E. cloacae,
P. aeruginosa, S. mercescens and S. typhi.
Conclusion: C. angustifolia extracts revealed the presence of quercimeritrin (1), scutellarein (2), and rutin (3), all
known to have useful bioactivities including antimicrobial, antioxidant and anticancer activities.
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Background
In recent years, there has been an alarming increase in the
antibiotic resistance to a broad range of human patho-
genic bacterial and fungal strains which contribute to the
recurrence of infectious diseases. Urinary tract, blood-
stream, and respiratory organs are some of the common
sites of infections caused by antibiotic resistance microbes
throughout the world [1]. Multidrug-resistant bacterial
and fungal strains are the main cause of hospital acquired
infections which reduce the efficacy of drugs and are
ultimately responsible for treatment failure [2]. This situ-
ation has created a need to find more effective drugs.
Natural products from microorganisms have been the
primary source of antibiotics, and with the increasing
acceptance of herbal medicines, the screening of medi-
cinal plants for new active compounds has become a very
important source of novel antibiotics [3].
Extensive researches on medicinal plants have also in-
dicated that they are good sources of antioxidants [4–6].
They are involved in free radical scavenging activities
which contribute to the protection from oxidative stress
caused by the overproduction of free radicals and react-
ive oxygen species [7]. These are produced as bypro-
ducts of various biochemical and physiological processes
in the human body [8]. Biomolecular body systems such
as lipids, DNA, RNA and proteins are adversely affected
by the oxidative stress which eventually leads to human
chronic diseases such as Alzheimer’s, cardiovascular, ath-
erosclerosis, cancer, stroke, fibrosis, aging and diabetes [9].
According to many research reports, the consumption of
medicinal plants either in the form of raw extracts or
chemical constituents is largely associated with lower risk
of degenerative diseases caused by oxidative stress because
they contain antioxidants such as phenolics, flavonoids,
vitamins and carotenoids [10]. Phenolic compounds such
as phenolic acids and flavonoids are reported to be
involved in various biochemical activities like antioxidant,
antimicrobial, antithrombotic, antiartherogenic, anti-
inflammatory, anticarcinogenic and antimutagenic [11].
Natural antioxidants of plant origin are usually more
potent and beneficial than synthetic antioxidants such as
propylgallate (PG), butylated hydroxytoluene (BHT), t-
butylhydroxytoluene (TBH) and butylated hydroxyanisole
(BHA) [12]. It was also reported that synthetic antioxi-
dants were the cause of carcinogenesis and liver damage
in laboratory animals [13]. Thus there is a need to explore
and develop antioxidants of natural origin with greater
efficacy and fewer side effects.
Cancer is the second largest cause of death worldwide
[14]. Although great advancements have been made in
the treatment and control of cancer progression, signifi-
cant deficiencies and room for improvement remains. A
number of undesired side effects sometimes occur
during chemotherapy. Natural therapies, such as the use
of plant-derived products in cancer treatment, may re-
duce adverse side effects. There are many natural prod-
ucts including phytochemicals and dietary compounds
from vegetables, plants, spices and herbs that have been
used for the treatment of cancer throughout history due
to their safety, low toxicity, and general availability [15].
C. angustifolia Vahl. is a traditional medicinal plant
belonging to the family Caesalpiniaceae. It is commonly
known as senna makkai or cassia senna. C. angustifolia
is native to Saudi Arabia, Egypt, and Yemen. It is a
rapid-growing shrub 5–8 m tall, extensively cultivated
for its fruit and leaves in hot arid areas of Pakistan [16].
This plant is recognized in British and USA pharmaco-
poeias [17]. The leaves and pods of C. angustifolia are
used in the form of a decoction powder for intestinal
worms as an anti-helmenthic. It is also widely used as an
anti-pyretic in typhoid, splenic enlargements, cholera,
laxative, anemia, toxicity and genotoxicity caused by
Escherichia coli [16].
Worldwide consumption of C. angustifolia as a folk
medicine against various ailments and the studies reported
in the literature demand further research to discover the
compounds responsible for its bioactivities. This research
study was conducted to investigate the antibacterial,
antifungal, antioxidant, and anticancer potentials of
aqueous as well as organic extracts of C. angustifolia.
They were also subjected to phytochemical screening
to determine the presence of secondary metabolites
and bioactive compounds.
Methods
Formulation of plant crude extracts
C. angustifolia seed powder were bought from a local
herb shop in Islamabad and is identified by taxonomist Dr.
Muhammad Qasim Hayat, ASAB (Atta-ur-Rahman School
of Applied Biosciences), NUST (National University of
Sciences and Technology), Islamabad. It was identified by
comparing with the voucher specimen no P03088812 of
Herbier museum Paris (http://mediaphoto.mnhn.fr/media/
1441330963480e0yHgeqQ0CSk9mGW). The local botan-
ical description of C. angustifolia is also available at flora
of Pakistan (http://www.tropicos.org/Name/13028414?pro
jectid=32) and original plant material was kept at MPRL
(Medicinal Plant Research Laboratory), ASAB, NUST for
future references. Extracts were formulated by maceration.
The finely ground powder (mesh size 50 = 0.297 mm) was
subjected to aqueous and organic solvents (methanol,
ethanol, acetone, and ethyl acetate) separately in flasks
with the ratio 1:10 and placed in the dark at 37 °C for three
days with intermittent shaking. Centrifugation was per-
formed for 15 min at 2000 rpm. Supernatants were filtered
with Whatman filter paper no.1. The filtrate was trans-
ferred to a round-bottom flask and the solvent was rotary
evaporated. The dry extract was stored at 4 °C.
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Bacterial and fungal strains
Acinetobacter junii IARS2, Serratia mercescens IARS6,
Enterobacter cloacae IARS7, Pseudomonas aeroginosa
IARS8 and Salmonella typhi ATCC 14079 were used in
antibacterial assays. Glycerol stocks of all the bacterial
strains were maintained in controlled conditions and
subcultured on Mueller Hinton agar for 24 h before
antibacterial assay. The fungal strain Candida albicans
was obtained from the Institute of Biotechnology and
Genetic Engineering (IBGE), Abdul Qadeer Khan
Research Laboratory (KRL) Hospital, Islamabad. It was
maintained at 37 °C on Sabouraud dextrose agar.
Antimicrobial assay
Organic and aqueous extracts of C. angustifolia were
screened for antibacterial and antifungal potential by disk
diffusion assay as previously reported [18].
Antioxidant assay
The antioxidant activities of the organic and aqueous
extracts of C. angustifolia and gallic acid were evaluated
with the DPPH method as previously described [19].
Antioxidant potential of C. angustifolia extracts were
analyzed and mentioned as IC50, which was calculated




The HeLa was provided by HBV (Hepatitis B Virus) lab,
ASAB, NUST. Hep2, MCF-7, and HCEC were provided
by IBGE, KRL Hospital, Islamabad. All the cell lines
were grown in RPMI-1640 media which contained 10 %
FBS. All cells were maintained at 37 °C in a humidified
atmosphere of 5 % CO2.
MTT assay
Anticancer assay of C. angustifolia on Hep2, HeLa, MCF-
7, and HCEC were carried out by the MTT colorimetric
assay as employed earlier [20]. The anticancer activities of
each tested extract were presented as IC50, which was
calculated by percentage cell death at 100 μg/μL, 150 μg/
μL, 200 μg/μL, 250 μg/μL using MS excel 2010.
Qualitative phytochemical screening for secondary
metabolites
C. angustifolia extracts were phytochemically screened
for the presence of secondary metabolites. Qualitative
phytochemical analyses for the presence of steroids,
alkaloids, tannins including phlobatannins, monoter-
penes, flavonoids, coumarins, cardiac glycosides, sapo-
nins, diterpenes, anthraquinones, and phenols were
carried out by standard protocols [21–23].
Determination of total phenolic contents
Total phenolic contents of the organic and aqueous
extracts of C. angustifolia were determined by the Folin-
Ciocalteu method [24].
Determination of total flavonoid contents
The total flavonoid contents of C. angustifolia extracts
were determined by the aluminum chloride colorimetric
method [19].
Isolation of active compounds
The C. angustifolia extracts were submitted to HPLC-
MS analysis for screening of active compounds. A
Shimadzu preparative HPLC, equipped with an LC-
20 AD pump (the make-up pump), two LC-8A pumps
(the gradient pumps), an SPD-20A UV detector and a
CTC analytics PAL sample injector and fraction collector
were used for the isolation of compounds. The fractions
were collected based on UV @ 214 nm. The column used
was a Phenomenex Gemini-NX C18 (30 × 50 mm i.d.,
5 μm particle size, 110 A). The injection volumes were
800 to 1200 μL. The gradient was 5 to 70 % acetonitrile
over 25 min with a flow rate of 35 mL/min. The modifier
was 0.1 % formic acid, used primarily for ionization.
Identification of active compounds
The structural identifications of isolated compounds
were carried out by 1H NMR analysis. 1H NMR data
were obtained by using a Bruker AVANCE III 400 MHz.
NMR spectrometer equipped with a PA BBO 400S1
probe and a sample jet autosampler.
Statistical analysis
All the experiments were carried out in triplicate. Data
were presented as mean ± SD. T-Test was performed to
determine statistical significance. Microsoft Excel 2010
was used for the statistical and graphical evaluations.
Results
Antimicrobial activity
The antibacterial activities of different extracts of C. angu-
stifolia and controls are shown in Tables 1 and 2. All the
tested pathogenic bacterial strains were sensitive to C.
angustifolia extracts. Extracts of C. angustifolia showed
variable degrees of bactericidal activity, with inhibitory
effects of methanol extracts being observed against all of
the selected bacterial strains. The highest bactericidal
activity of the ethyl acetate extract was recorded against S.
mercescens, with a 10.5 ± 0.76 mm zone of inhibition at
1.25 mg/mL. It was observed that A. junni, E. cloacae and
P. aeroginosa were resistant to aqueous extract. The etha-
nol extract showed no antibacterial activity against E.
faecalis and P. aeruginosa, while it showed its best anti-
bacterial activity against S. mercescens with a 9.0 ±
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Table 1 Zone of inhibition of C. angustifolia extracts against pathogenic bacterial and fungal strains
Microrganisms Extracts Zones of Inhibition (mm)
1.25 mg/mL 2.5 mg/mL 5 mg/mL 10 mg/mL
Acinetobacter junii Methanol 0.0 ± 0.0 0.0 ± 0.0 7.5 ± 0.1** 10 ± 0.2**
Acetone 0.0 ± 0.0 0.0 ± 0.0 7.9 ± 0.1** 9.5 ± 0.1**
Ethyl acetate 0.0 ± 0.0 8.0 ± 0.2** 10.5 ± 0.2** 11 ± 0.36**
Ethanol 0.0 ± 0.0 0.0 ± 0.0 8.0 ± 0.36** 10 ± 0.2**
Aqueous 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Serratia mercescens Methanol 8.5 ± 0.2** 8.8 ± 0.3** 10.8 ± 0.26* 11.6 ± 0.2**
Acetone 9.5 ± 0.36** 9.7 ± 0.17** 10.5 ± 0.60* 12.8 ± 1**
Ethyl acetate 10.5 ± 0.26* 10.8 ± 0.1** 11.6 ± 1.2* 12.5 ± 1.1*
Ethanol 9.0 ± 0.60** 10.0 ± 0.17** 12.1 ± .95* 13.3 ± 0.51**
Aqueous 7.3 ± 0.33** 7.8 ± 0.57** 9.0 ± 0.60** 10.0 ± 0.20**
Enterobacter cloacae Methanol 7.3 ± 0.26** 7.5 ± 0.20** 8.6 ± 0.36** 10.6 ± 0.20**
Acetone 0.0 ± 0.0 0.0 ± 0.0 7.5 ± 0.3** 8.5 ± 0.1**
Ethyl acetate 7.8 ± 0.78* 8.5 ± 0.1** 10.5 ± 0.26** 12.5 ± 0.50**
Ethanol 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Aqueous 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Pseudomonas aeruginosa Methanol 7.5 ± 0.20** 8.5 ± 0.1** 10.0 ± 0.20** 12.1 ± 0.43**
Acetone 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Ethyl acetate 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Ethanol 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Aqueous 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Salmonella typhi Methanol 7.8 ± 0.3** 8.8 ± 0.52** 10.8 ± 0.65** 12.17 ± 0.43**
Acetone 7.1 ± 0.6* 7.8 ± 0.30** 8.2 ± 0.36** 8.9 ± 0.43**
Ethyl acetate 8.8 ± 0.28** 9.3 ± 0.45** 10.0 ± 0.20** 12.5 ± 0.62**
Ethanol 7.1 ± 0.26** 8.0 ± 0.34** 10.5 ± 0.50** 11.8 ± 0.40**
Aqueous 7.6 ± 0.40** 8.8 ± 0.40** 9.5 ± 0.43** 10.0 ± 0.34**
Candida albicans Methanol 8.5 ± 0.30** 10.5 ± 0.78** 11.5 ± 0.36** 12.0 ± 0.8**
Acetone 10 ± 0.34** 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Ethyl acetate 9.0 ± 0.20** 9.5 ± 0.51** 10 ± 0.20** 0.0 ± 0.0
Ethanol 10.0 ± 0.1** 10.8 ± 0.40** 11.0 ± 1.3* 11.3 ± 0.55**
Aqueous 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Each value represents the mean ± standard deviation of three replicates (n = 3)
(*), and (**), significant at level P ≤ 0.01 and 0.001, respectively
Table 2 Zone of inhibition of positive and negative controls against pathogenic bacterial and fungal strains
Controls Chemicals Zone of Inhibition (mm)






















Negative DMSO(a) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Values are expressed as mean ± SD (n = 3). (a) Dimethylsulfoxide
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0.50 mm zone of inhibition at 1.25 mg/mL. A. junii, S.
mercescens, E. cloacae, and S. typhi were sensitive to acet-
one extract. Tigecycline, amikacin and cefepime (5 μg/
mL) were used as standard antibiotic drugs (Table 2).
The antifungal potential of the extracts were measured
in terms of clear zone of inhibition of fungal growth
(Table 1). All the tested C. angustifolia extracts had
significant antifungal activity. The methanol extract
exhibited the highest antifungal activity with a zone of
inhibition of 12 mm at 10 mg/mL as compared to the
standard amikacin drug which is sensitive to fungal
growth. The aqueous extract showed no significant anti-
fungal activity while the ethanol and ethyl acetate
extracts showed moderate antifungal activity with zones
of inhibition of 11 and 10 mm, respectively.
Antioxidant assay
The antioxidant activities of the aqueous and organic
extracts of C. angustifolia and gallic acid were evaluated
by the free radical DPPH scavenging test on the basis of
IC50 values (Table 3). IC50 values are the inhibitory con-
centrations required for 50 % scavenging of DPPH free
radicals. The smaller the IC50 values, the higher the anti-
oxidant potential of the plant constituents. The absorb-
ance values of different extracts of C. angustifolia and
standards were measured at the wavelength 517 nm.
The resulting absorbance of the extracts give percentage
scavenging of DPPH free radicals. All the extracts have
dose dependent antioxidant activities, i.e., the scavenging
activities of the extracts increased with the respective in-
crease in the concentrations (Fig. 1). According to the
results, all the extracts have potential antioxidant activ-
ities. The ethanol extracts exhibit maximum DPPH free
radical scavenging activity (93 %) at a concentration of
500 μg/mL with an IC50 value of 2.41 ± 0.02 μg/mL,
whereas the aqueous extract showed poor DPPH scaven-
ging activity (68 %) at 500 μg/mL with IC50 values of
3.03 ± 0.04 μg/mL. The other C. angustifolia extracts
showed moderate DPPH scavenging activities (Fig. 1).
Anticancer assay
The cytotoxic studies for C. angustifolia extracts employed
the MTT colorimetric method. The C. angustifolia aque-
ous, methanol, ethanol, acetone and ethyl acetate extracts
were investigated first time for their anticancer potential
against Hep2, HeLa, MCF-7 and normal HCEC cell lines.
Only the ethanol extract exhibited anticancer activity, with
28 % death in Hep2 cells with an IC50 of 7.28 μg/μL.
Methanol and ethanol extracts exhibited 33 and 23 % cell
death in HeLa cell lines and 43 and 23 % cell death in
MCF-7 cell lines (Table 4). The IC50 values are used to
find the potency of drugs, lower IC50 values mean more
potent the drugs. It was observed that IC50 value of
methanol extract is 5.45 μg/μL against HeLa cells and
4 μg/μL against MCF-7 cells which are far less than the
IC50 value of standard anticancer drug taxol 6.07 μg/μL
and tamoxifen 6.4 μg/μL. C. angustifolia methanol and
ethanol extracts were further examined for cytotoxicity
against the normal cell line to answer whether it is select-
ive towards cancerous cells. For this, normal HCEC cells
were incubated with different concentrations of methanol
and ethanol extracts (100, 150, 200 and 250 μg/μL) to
analyze cell viability. The data showed that HCEC cells
were unaffected by exposure to methanol and ethanol
extracts. It showed ca. 100 % cell viability against different
concentrations of methanol and ethanol extract. These re-
sults showed that methanol and ethanol extracts have the
potential to inhibit the proliferation of Hep2, HeLa, and
MCF-7 cells. These cells were more sensitive to inhibition
by C. angustifolia extract than normal HCEC cell lines.
Phytochemical screening
Qualitative phytochemical screening of different extracts
of C. angustifolia revealed the presence of steroids, alka-
loids, tannins including phlobatannins, monoterpenes,
flavonoids, coumarins, cardiac glycosides, saponins, di-
terpenes, anthraquinones, and phenols which contribute
to the antimicrobial, antioxidant and anticancer activities
of the plant (Table 5).
Total phenolic contents
Total phenolic contents in the aqueous and organic ex-
tracts of C. angustifolia were evaluated by plotting a stand-
ard curve using different concentrations of GAE (Gallic
acid equivalent) with their respective absorbance at
700 nm. The linear regression equation [y =0.504× (R2 =
0.991)] for the calibration curve was used to evaluate the
total amount of phenolic contents present in each extract
which was expressed as mg of GAE/g (Table 6). The ana-
lysis showed that a considerable amount of phenolic con-
tents were present in organic and aqueous extracts of C.
angustifolia ranging from 0.535 ± 0.002 to 2.328 ± 0.003 mg
of GAE/g of extract. The methanol and ethanol extracts
Table 3 IC50 of free radical scavenging activity of standards and
different extracts of C. angustifolia
Test material DPPH radical IC50 in μg/mL
Plant extracts Methanol 2.49 ± 0.01*
Ethanol 2.41 ± 0.02*
Acetone 3.06 ± 0.04**
Ethyl acetate 2.74 ± 0.02*
Aqueous 3.03 ± 0.04**
Standards Gallic acid 2.52 ± 0.02
Ascorbic acid 2.54 ± 0.00
Each value represents the mean ± standard deviation of three replicates (n = 3)
(*), and (**), significant at level P ≤ 0.01 and 0.001, respectively
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have the most phenolic contents followed in order by the
ethyl acetate, acetone and aqueous extracts.
Total flavonoid contents
The total flavonoid contents were determined by plot-
ting a standard curve using different concentrations of
QE (Quercetin equivalent) with their absorbance at
510 nm. The linear regression equation [y =0.040× (R2
= 0.975)] of the calibration curve was used to evaluate
the total amount of flavonoid contents present in each
extract which is expressed as mg of quercetin equiva-
lents per gram QE/gm (Table 6). Methanol extracts of
C. angustifolia showed higher content of flavonoids
than the other solvent extracts.
HPLC analysis
Bioactivity-guided screening of C. angustifolia methanol,
ethanol and ethyl acetate extracts by HPLC-MS revealed
the presence of three bioactive compounds: quercimeri-
trin (1), scutellarein (2), and rutin (3).
Quercimeritrin (1)
C21H20O12, yellow amorphous powder;
1H NMR
(400 MHz, CD3OD) δ: 3.48-3.98 (6H, m, H-2”, H-3”,
H-4”, Ha-5”, Hb-5”), 5.25 (1H, d, J = 8 Hz, H-1”), 6.25
(1H, d, J = 2 Hz, H-8), 6.48 (1H, d, J = 2 Hz, H-6),
6.86 (1H, d, J = 8.5 Hz, H-5’), 7.63 (1H, dd, J = 8.5,
2.5 Hz, H-6’), 7.67 (1H, d, J = 2.0 Hz, H-2’). ESIMS




1H NMR (400 MHz,
CD3OD) δ: 6.22 (1H, s, H-3), 6.76 (2H, d, J = 8, H-3’,5’),
7.09 (2H, d, J = 8, H-2’,6’), 7.11 (1H, s, H-8). ESIMS m/




1H NMR (400 MHz,
CD3OD) δ: 1.15 (3H, d, J = 6, H-6”’), 3.27 (1H, m, H-4”’),
3.45 (1H, m, H-5”’), 3.56 (1H, dd, J = 9.5/3.5 Hz, H-3’”),
Fig. 1 Graph showing DPPH radical scavenging activity of different extracts of C. angustifolia. Each point represents the mean of three
experiments. Data are expressed as mean ± standard deviation. (#) indicated values are not significant at P < 0. 05
Ahmed et al. BMC Complementary and Alternative Medicine  (2016) 16:460 Page 6 of 9
3.65 (1H, dd, J = 3.5/1.5, H-2’”), 3.26-3.53 (6H, m, H-2”,
H-3”, H-4”, Ha-5”, Hb-5”), 5.13 (1H, d, J = 7.8 Hz, H-1”),
6.24 (1H, d, J = 1.8 Hz, H-6), 6.43 (1H, d, J = 2.2 Hz, H-8),
6.90 (1H, d, J = 8.0 Hz, H-3’), 7.65 (1H, dd, J = 8.0/1.8, H-
2’), 7.69 (1H, d, J = 1.8 Hz, H-6’). ESIMS m/z 610.16 [M]+,
611.16 [M+H]+, 633.15 [M+Na] +, 609.15 [M-H]−.
Discussion
Medicinal plants are important sources of biologically
active natural products which due to their curative prop-
erties have been studied for many years [25, 26]. The
present study was designed to find the bactericidal
potential of extracts of C. angustifolia. A. junii, S.
mercescens, E. cloacae, P. aeroginosa, and S. typhi have
been implicated in the pathogenesis of various infectious
diseases [27]. Among the extracts, the methanol extract
of C. angustifolia displayed the highest activity and a
broad spectrum of activity against pathogenic bacterial
strains. It was reported that the bactericidal activity was
due to the presence of flavonoids found in the methanol
extract [28]. It was studied that methanol and ethanol
extracts of C. angustifolia possess significant antibacter-
ial activity against E. coli, Klebsiella pneumoniae and
Shigella shinga [17]. The current findings suggest that
methanol, ethanol and ethyl acetate extracts are rich in
flavonoids which are responsible for antimicrobial activ-
ities. Flavonoids including rutin (3) have been reported
to have antimicrobial activities against resistant bacterial
strains [29]. The aqueous extract of C. angustifolia was
not active at the highest concentrations tested against A.
junni, E. cloacae and P. aeroginosa. It was reported that
Table 4 Anticancer activity of C. angustifolia extracts against HCEC, Hep2, HeLa, and Mcf-7cell lines
Cell
Lines
Extracts % Cell death I.C50
100 μg/μL 150 μg/μL 200 μg/μL 250 μg/μL μg/μL
HCEC Methanol 2.3 ± 0.76 1.83 ± 0.76 3.43 ± 0.50* 13.7 ± 2.42* 21.09
Ethanol 1.2 ± 0.52 6.23 ± 1.02* 9.20 ± 0.81* 12.8 ± 1.01* 16.23
Taxol 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0
Tamoxifen 14.5 ± 0.5 19.3 ± 0.7 26 ± 0.5 26.8 ± 0.7 6.29
Hep2 Ethanol 6.06 ± 0.49** 11.83 ± 0.65** 21.0 ± 0.90* 28.26 ± 0.25* 7.28
Taxol 26.5 ± 0.5 31.76 ± 0.66 35.53 ± 0.25 45.16 ± 0.60 3.97
HeLa Methanol 16.7 ± 0.70** 22.56 ± 0.40** 27.73 ± 0.2** 32.46 ± 0.61** 5.45
Ethanol 5.46 ± 0.40** 15.53 ± 0.37** 18.43 ± 0.4** 22.9 ± .075** 8.18
Taxol 11.46 ± 0.40 19.7 ± 0.51 24.63 ± 0.50 30.56 ± 0.45 6.07
MCF-7 Methanol 23.33 ± 0.7** 26.23 ± 0.25** 42.4 ± 0.36** 43.6 ± 0.45** 4.0
Ethanol 6.8 ± 0.52* 11.5 ± 0.37** 16.1 ± 0.1** 23.56 ± 0.45** 8.79
Tamoxifen 12.46 ± 0.40 17.36 ± 0.55 24.63 ± 0.50 28.56 ± 0.45 6.4
Taxol and Tamoxifen are standard anticancer drugs taken as positive controls. Values represents the mean ± standard deviation of three replicates (n = 3)
(*), and (**), significant at level P ≤ 0.01 and 0.001, respectively
Table 5 Phytochemical screening for secondary metabolites of
different solvent extracts of Cassia angustifolia
EXTRACTS Methanol Ethanol Acetone Ethyl acetate Aqueous
Steroids + + + + +
Alkaloids + + - + -
Tannins + + - + +
Phlobatannins + + + + +
Monoterpenes + + + + +
Flavonoids + + + + +
Coumarins + + - - +
Cardiac
Glycosides
+ + + + +
Saponins + + + + +
Diterpenes + - - - +
Anthraquinones + + - - +
Phenols + + + + +
(+) = present (−) = absent
Table 6 Quantification of phenols and flavonoids in different












1 Methanol 2.328 ± 0.003** 5.00 ± 0.04**
2 Ethanol 1.769 ± 0.001** 3.73 ± 0.08**
3 Acetone 1.535 ± 0.004** 3.31 ± 0.06**
4 Ethyl acetate 1.318 ± 0.002* 3.70 ± 0.04**
5 Aqueous 0.535 ± 0.002** 1.29 ± 0.03**
Values are expressed as mean ± standard deviation mg of the extracts
(observations of three replicates of each sample extract)
(*), and (**), significant at level P ≤ 0.01 and 0.001, respectively
(a) Gallic Acid Equivalent per gram of dry weight (mg GAE/gm). (b) Quercetin
Equivalent per gram of dry weight (mg QE/gm)
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this was due to the lower extraction of antimicrobial
compounds into the aqueous extract or to minimum
availability of the aqueous extract to the microorganism
[30]. It was also reported that the n-butanol extract of C.
angustifolia showed maximum antibacterial potential
against S. aureus and typhi with 13 and 15 mm zones of
inhibition, respectively [31]. The current study revealed
that A.junii, S. mercescens and P. aeroginosa show resist-
ance against the standard antibiotics amikacin and cefe-
pime, while these bacterial strains showed sensitivity to
C. angustifolia extracts. The current study also showed
that C. angustifolia exhibits potential fungicidal property
against C. albicans. It was shown earlier that saponins,
active ingredients of C. angustifolia, were involved in an-
tifungal activity against Colletotridium dematium [32]. It
was reported earlier that a butanol extract of C. angusti-
folia exhibited antifungal activity against Aspergillus
terrus, A. flavus and A. niger [31]. The antimicrobial ac-
tivities of medicinal plants were due to the presence
phytochemicals including saponins, terpenoids, flavo-
noids, phenolics, and alkaloids [33].
In the present study, antioxidant activities of C. angu-
stifolia extracts revealed that methanol, ethanol, ethyl
acetate and acetone exhibited significantly higher scav-
enging percentages and are correlated by phenolic com-
pounds. Phenolics and flavonoids are secondary
metabolites derived from tyrosine and phenylalanine
with potent antibacterial and antioxidant activities [34].
It was reported that isolated flavonoids quercimeritrin
(1), scutellarein (2), and rutin (3) have significant anti-
oxidant activities against oxidative stress [35–37]. Note
that all three have 1,2-dihydroxybenzene groups which
are readily oxidized to orthoquinones, making them
strong antioxidants. The aqueous extract showed a poor
DPPH-scavenging activity of 67.7 %. This is because the
flavonoids and phenols responsible for antioxidant activ-
ity are poorly extracted into the aqueous extract [38].
No detailed anticancer study of C. angustifolia has been
reported earlier. This study was carried out to evaluate
the anticancer potential of C. angustifolia and it revealed
that methanol and ethanol extracts of C. angustifolia ex-
hibit anticancer properties. It was reported earlier that
secondary metabolites like flavonoids can be responsible
for anticancer activities [29]. The current study supports
the idea that the anticancer activity is due to the pres-
ence of isolated flavonoids, which were found in metha-
nol and ethanol extracts of C. angustifolia. It was
investigated earlier that scutellarien (2), extracted from
Scutellaria lateriflora, possesses anticancer activity by
significantly suppressed the proliferation of HT1080 hu-
man fibrosarcoma cells through induction of apoptosis
[39]. In a similar study, it was revealed from the in vivo
experiment that that the size and weight of the tumor
was reduced after treatment with scutellarein (2) [40].
On the other hand, rutin (3) has been reported as anti-
cancer agent by inducing apoptosis and cell cycle arrest
in murine leukemia WEHI-3 cells [41]. It was also re-
ported that rutin (3) had the potential to kill the breast
cancer cells in MDA-MB-231 cell line [42]. Based on the
findings, the current study supports the hypothesis that
antimicrobial, anticancer and antioxidant activities of C.
angustifolia are due to at least in part to the presence of
isolated flavonoids.
Conclusions
The present study was carried out to explore antimicro-
bial, antioxidant, and anticancer potential of C. angusti-
folia. Maximum antioxidant and anticancer activities
were observed for methanol, ethanol and ethyl acetate
extract which was correlated with phenolic and flavon-
oid contents. Bioactivity-guided screening of methanol,
ethanol and ethyl acetate extracts revealed the presence
of quercimeritrin (1), scutellarein (2), and rutin (3), all
known to have useful bioactivities including antimicro-
bial, antioxidant and anticancer activities. These findings
shows the importance of screening medicinal plants for
antimicrobial, anticancer and antioxidant agents against
resistant bacterial strains, various cancers and degenera-
tive diseases caused by oxidative stress.
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